← Eichor
Condition: Vte Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Vte

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis
Phase 3 · 8 location(s) · Marc Blondon · NCT07140211REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Particip
Phase 3 · 32 location(s) · Regeneron Pharmaceuticals · NCT07213778Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung C
Phase N/A · 1 location(s) · University Of Perugia · NCT07288632AQT90 FLEX D-dimer Clinical Sensitivity and Specificity
Phase N/A · 1 location(s) · Radiometer Medical ApS · NCT06749223Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk o
NA · 13 location(s) · University Hospital, Brest · NCT06372730Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
Phase N/A · 1 location(s) · The First Hospital of Jilin University · NCT07439991The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Phase 3 · 3 location(s) · Quercis Pharma AG · NCT06861088Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism
Phase 3 · 7 location(s) · Ottawa Hospital Research Institute · NCT06393868Excretion of Rivaroxaban in Human Breast Milk
Phase 1 · 1 location(s) · Thomas Jefferson University · NCT06831474Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
Phase N/A · 4 location(s) · Diagnostica Stago R&D · NCT06480994PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
Phase 3 · 12 location(s) · Sunnybrook Health Sciences Centre · NCT03559114Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism
NA · 6 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07143539Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking
Phase N/A · 4 location(s) · Argon Medical Devices · NCT07102160Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Phase 2 · 1 location(s) · University of Miami · NCT04295486Pregnancy and Risk of Venous Thromboembolism
NA · 1 location(s) · Hospices Civils de Lyon · NCT03659708CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
NA · 1 location(s) · China-Japan Friendship Hospital · NCT04211181Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial
Phase 4 · 1 location(s) · Clinical Urology and Epidemiology Working Group · NCT06523959Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
NA · 1 location(s) · Scott C. Woller, MD · NCT06232551Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study
Phase N/A · 3 location(s) · University of Dublin, Trinity College · NCT07196020REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Phase 3 · 46 location(s) · Regeneron Pharmaceuticals · NCT07015905Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk
Phase 4 · 18 location(s) · University Hospital, Brest · NCT06845423Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis
Phase 4 · 1 location(s) · Science Valley Research Institute · NCT06958588VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratifi
Phase N/A · 1 location(s) · Johannes Gutenberg University Mainz · NCT02156401REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Phase 3 · 13 location(s) · Regeneron Pharmaceuticals · NCT07410117Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant
NA · 14 location(s) · McMaster University · NCT06957366A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery
Phase N/A · 1 location(s) · RenJi Hospital · NCT06259149VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Phase 4 · 1 location(s) · Science Valley Research Institute · NCT06873321Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies
NA · 1 location(s) · Medical University of Gdansk · NCT07270263Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam
Phase N/A · 1 location(s) · Hieu Trung Dinh · NCT07083609Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eA
NA · 1 location(s) · Brigham and Women's Hospital · NCT03728166
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.